Overdose of the histamine H3 inverse agonist pitolisant increases thermal pain thresholds

被引：0
|
作者：
Dong Dong Zhang
Marco Sisignano
Claus Dieter Schuh
Kerstin Sander
Holger Stark
Klaus Scholich
机构：
[1] Hospital of the Goethe-University Frankfurt,Institute of Clinical Pharmacology, pharmazentrum frankfurt, ZAFES
[2] Goethe University Frankfurt,Institute of Pharmaceutical Chemistry, ZAFES/LiFF/NeFF
来源：
Inflammation Research | 2012年 / 61卷
关键词：
Histamine receptor 3; Pitolisant; Ciproxifan; Pain; Thermal hyperalgesia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1283 / 1291
页数：8
相关论文
共 50 条
  • [21] ANTICATAPLECTIC EFFICACY OF PITOLISANT, THE FIRST POTENT AND HIGHLY SELECTIVE HISTAMINE H3-RECEPTOR ANTAGONIST/INVERSE AGONIST
    Thorpy, M.
    Schwartz, J.
    Lecomte, J.
    Causse, C.
    Dayno, J. M.
    SLEEP, 2018, 41 : A232 - A232
  • [22] Cardiovascular effects of H3 histamine receptor inverse agonist/H4 histamine receptor agonist, clobenpropit, in hemorrhage-shocked rats
    Wanot, Bartosz
    Jasikowska, Karolina
    Niewiadomska, Ewa
    Biskupek-Wanot, Agnieszka
    PLOS ONE, 2018, 13 (08):
  • [23] In vivo pharmacological profile of S 38093, a novel histamine H3 receptor inverse agonist
    Panayi, Fany
    Sors, Aurore
    Bert, Lionel
    Martin, Brigitte
    Rollin-Jego, Gaelle
    Billiras, Rodolphe
    Carrie, Isabelle
    Albinet, Karine
    Danober, Laurence
    Rogez, Nathalie
    Thomas, Jean-Yves
    Pira, Luigi
    Bertaina-Anglade, Valerie
    Lestage, Pierre
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 803 : 1 - 10
  • [24] INHIBITORY EFFECTS OF HISTAMINE H3 RECEPTOR (H3R) INVERSE AGONIST/ANTAGONIST ON MICROGLIAL FUNCTIONS
    Iida, T.
    Yoshikawa, T.
    Yanai, K.
    INFLAMMATION RESEARCH, 2018, 67 : S25 - S25
  • [25] Tolerance and pharmacokinetics of pitolisant (Wakix®), a histamine H3 antagonist, in 24 narcoleptic children
    Lecendreux, M.
    Plazzi, G.
    Franco, P.
    Robert, P.
    Duvauchelle, T.
    Lecomte, J. -M.
    JOURNAL OF SLEEP RESEARCH, 2016, 25 : 230 - 231
  • [26] TOLERANCE AND PHARMACOKINETICS OF PITOLISANT (WAKIX®), A HISTAMINE H3 ANTAGONIST, IN 24 NARCOLEPTIC CHILDREN
    Lecendreux, M.
    Plazzi, G.
    Franco, P.
    Robert, P.
    Duvauchelle, T.
    Lecomte, J. -M.
    SLEEP MEDICINE, 2017, 40 : E182 - E182
  • [27] The Evolution of Histamine H3 Antagonists/Inverse Agonists
    Lebois, Evan P.
    Jones, Carrie K.
    Lindsley, Craig W.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (06) : 648 - 660
  • [28] The impact of pitolisant, an H3 receptor antagonist/inverse agonist, on perirhinal cortex activity in individual neuron and neuronal population levels
    Hirano, Kyosuke
    Morishita, Yoshikazu
    Minami, Masabumi
    Nomura, Hiroshi
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [29] The impact of pitolisant, an H3 receptor antagonist/inverse agonist, on perirhinal cortex activity in individual neuron and neuronal population levels
    Kyosuke Hirano
    Yoshikazu Morishita
    Masabumi Minami
    Hiroshi Nomura
    Scientific Reports, 12
  • [30] Discovery and characterization of CEP-26401: A potent, selective histamine H3 receptor inverse agonist
    Hudkins, Robert L.
    Raddatz, Rita
    Tao, Ming
    Mathiasen, Joanne R.
    Grunner, John A.
    Aimone, Lisa D.
    Prouty, Catherine P.
    Becknell, Nadine C.
    Knutsen, Lars
    Yazdanian, Mehran
    Moachon, Gilbert
    Ator, Mark A.
    Mallamo, John P.
    Marino, Michael J.
    Bacon, Edward R.
    Williams, Michael
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
12345